Rat liver microsomal metabolism of o-aminophenol and N-(2-methoxyphenyl) hydroxylamine, two metabolites of the environmental pollutant and carcinogen o-anisidine in humans

Collection of Czechoslovak Chemical Communications

Volumn 75, Issue 12, 2010, Pages 1229-1247

  Naiman, Karel ^a   Hodek, Petr ^a   Liberda, Jiří ^a   Schmeiser, Heinz H ^b   Frei, Eva ^b   Stiborová, Marie ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Activation and detoxification; Metabolism; N (2 Methoxyphenyl)hydroxylamine; O Aminophenol; O Anisidine

Indexed keywords

EID: 78649800043     PISSN: 00100765     EISSN: None     Source Type: Journal    
DOI: 10.1135/cccc2010077     Document Type: Article

References (34)

1. International Agency for Research in Cancer (IARC): IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, No. 27. IARC, Lyon 1982.
2. Stabbert R., Schäfer K.-H., Biefel C., Rustemeier K.: Rapid Commun. Mass Spectrom. 2003, 17, 2125.
3. Kütting B., Göen T., Schwegler U., Fromme H., Uter W., Angerer J., Drexler H.: Int. J. Hyg. Environ. Health 2009, 212, 298.
4. Richter E., Rosler S., Scherer G., Gostomzyk J. G., Grubl A., Kamer U., Behrendt H.: Int. Arch. Occup. Environ. Health 2001, 74, 421.
5. Traupe H., Menge G., Kandt J., Karmaus W.: Dermatology 1997, 195, 112.
6. Stiborová M., Schmeiser H. H., Breuer A., Frei E.: Gen. Physiol. Biophys. 2001, 20, 267.
7. Stiborová M., Mikšanová M., Havlíček V., Schmeiser H. H., Frei E.: Mutat. Res. 2002, 500, 49.
8. Stiborová M., Mikšanová M., Šulc M., Rýdlová H., Schmeiser H. H., Frei E.: Int. J. Cancer 2005, 116, 667.
9. Rýdlová H., Mikšanová M., Ryšlavá H., Stiborová M.: Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2005, 49, 441.
10. Naiman K., Dračínská H., Martínková M., Šulc M., Dračínský M., Kejíková L., Hodek P., Hudecek J., Liberda J., Schmeiser H. H., Frei E., Stiborová M.: Chem. Res. Toxicol. 2008, 21, 1610.
11. Stiborová M., Mikšanová M., Smrček S., Bieler C. A., Breuer A., Schmeiser H. H., Frei E.: Carcinogenesis 2004, 25, 833.
12. Mikšanová M., Novák P., Frei E., Stiborová M.: Collect. Czech. Chem. Commun. 2004, 69, 589.
13. Akazawa M., Takasaki M., Tomoda A.: Tohoku J. Exp. Med. 2000, 192, 301.
14. Puiu M., Raducan A., Babaligea I., Oancea D.: Bioprocess Biosyst. Eng. 2008, 31, 579.
15. Balaban A. T., Garfield R. E., Lesko M. J., Seitz W. A.: Org. Prep. Proced. Int. 1998, 30, 439.
16. Dračínská H., Mikšanová M., Svobodová M., Smrček S., Frei E., Schmeiser H. H., Stiborová M.: Neuroendocrinol. Lett. 2006, 27 (Suppl. 2), 9.
17. Stiborová M., Martínek V., Rýdlová H., Hodek P., Frei E.: Cancer Res. 2002, 62, 5678.
18. Arlt V. M., Stiborová M., Henderson C. J., Thiemann M., Frei E., Aimová D., Singhs R., da Costa G. G., Schmitz O. J., Farmer P. B., Wolf C. R., Phillips D. H.: Carcinogenesis 2008, 29, 656.
19. Frei E., Bieler C. A., Arlt V. M., Wiessler M., Stiborová M.: Biochem. Pharmacol. 2002, 64, 289.
20. Gupta R. C., Reddy M. V., Randerath K: Carcinogenesis 1982, 3, 1081.
21. Randerath E., Agrawal H. P., Weaver J. A., Bordelon C. B., Randerath K.: Carcinogenesis 1985, 6, 1117.
22. Reddy M. V., Bleicher W. T., Blackburn G. R., Mackerer E. R.: Carcinogenesis 1990, 11, 1349.
23. Kim D., Kadlubar F. F., Teitel C. H., Guengerich F. P.: Chem. Res. Toxicol. 2004, 17, 529.
24. Kohno K., Miyake M., Sano O., Tanaka-Kataoka M., Yamamoto S., Koya-Miyata S., Arai N., Fujii M., Watanabe H., Ushio S., Iwaki K., Fukuda S.: Biol. Pharm. Bull. 2008, 31, 1938.
25. Uruma T., Yamaguchi H., Fukuda M., Kawakami H., Goto H., Kishimoto T., Yamamoto Y., Tomoda A., Kamiya S.: J. Med. Microbiol. 2005, 54, 1143.
26. Zheng C. L., Che X. F., Akiyama S., Miyazawa K., Tomoda A.: Int. J. Oncol. 2010, 36, 641.
27. Kirchner G., Bayer U.: Hum. Toxicol. 1992, 1, 387.
28. Brennan R. J., Schiestl R. H.: Mutagenesis 1997, 12, 215.
29. Okhuma Y., Kawanishi S.: Arch. Biochem. Biophys. 2001, 389, 49.
30. Cheng G., Shi Y., Sturla S., Jalas J., McIntee E. J., Villalta P. W., Wang M., Hecht S. S.: Chem. Res. Toxicol. 2003, 16, 145.
31. International Agency for Research in Cancer (IARC): IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 88, pp. 39-325. IARC, Lyon 2006.
32. U.S. Department of Health and Human Services: 11th Report on Carcinogens. U.S. Government Printing Office, Washington, DC 2004.
33. Dhareshwar S. S., Stella V. J.: J. Pharm. Sci. 2008, 97, 4184.
34. Imaoka S., Osada M., Minamiyama Y., Yukimura T., Toyokuni S., Takemura S., Hiroi T., Funae Y.: Cancer Lett. 2004, 203, 117.